Go to main content
Global

Product Overview

AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.

Critical Care

Argipressin AOP

Argipressin AOP is used to treat diabetes insipidus and bleeding from enlarged veins in the oesophagus.

Drug Facts
Active Ingredient
Argipressin
Critical Care

Empressin®

Empressin® is used for the treatment of catecholamine refractory hypotension following septic shock in patients older than 18 years. A catecholamine refractory hypotension is present if the mean arterial blood pressur cannot be stabilized to 65 – 75 mmHg despite adequate volume substitution and application of catecholamines.

Drug Facts
Active Ingredient
Agripressin
Critical Care

Esmocard® Lyo Esmolol Amomed

Esmolol hydrochloride is indicated for supraventricular tachycardia (except for pre-excitation syndromes) and for the rapid control of the ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable. Esmolol hydrochloride is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia where, in the physician’s judgement the rapid heart rate requires specific intervention.

Drug Facts
Active Ingredient
Esmolol
Critical Care

Nalbuphin Amomed®

Indicated for the management of moderate to pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Drug Facts
Active Ingredient
Nalbuphine
Critical Care

Nalpain®

is prescribed for short-term relief of moderate to severe pain e.g. post-surgery, in labour pain and gynecology, in myocardial infarction. Antagonizing an opioid induced respiratory depression, e.g. following fentanyl-combined narcosis. use in a combined narcosis ."

Drug Facts
Active Ingredient
Nalbuphine
Critical Care

Nexodal

Complete or partial reversal of CNS depressive effects, especially respiratory depression, caused by natural or synthetic opioids and partial agonist/antagonist opioids. It is also used to diagnose a suspected acute opioid overdose or intoxication or to reduce the effect of opioids, which were used for anesthesia in operations.

Drug Facts
Active Ingredient
Naloxone
Critical Care

Noradrenalin Orpha

Indicated for the management of moderate to pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Drug Facts
Active Ingredient
Noradrenaline
Critical Care

PONVeridol®

is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.

Drug Facts
Active Ingredient
Droperidol
Critical Care

Rapibloc ®

Landiolol hydrochloride is indicated for supraventricular tachycardia and for rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable. Landiolol hydrochloride is also indicated for non-compensatory sinus tachycardia where, in the physician’s judgment the rapid heart rate requires specific intervention. Landiolol is not intended for use in chronic settings.

Drug Facts
Active Ingredient
Landiolol
Critical Care

Siroctid

Drug Facts
Active Ingredient
Octreotide